Skip to main content
Premium Trial:

Request an Annual Quote

Awaiting Further Approvals, BGI-Shenzhen Extends Offer for Complete Genomics

NEW YORK (GenomeWeb News) – BGI-Shenzhen said after the market closed on Friday that it is extending its cash offer for Complete Genomics to midnight EST Jan. 25.

The deal had previously been extended to midnight EST Jan. 18.

The $118 million acquisition is awaiting approval from China's Ministry of Commerce and China's State Administration of Foreign Exchange. The National Development and Reform Commission in China already cleared the deal, as has the US Federal Trade Commission.

The depository for the offer said that as of the close of the business day on Jan. 18 about 30,620,053 shares, or 86 percent, of the common stock of Complete Genomics have been validly tendered and not withdrawn.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.